Cryotherapy Benefits: What the Research Says About Whole-Body Cold Exposure

- At a Glance
- How Cryotherapy Works: The Physiology of Extreme Cold
- Inflammation Reduction
- Pain Management
- Inflammatory Joint Conditions
- Fibromyalgia
- Post-Surgical Pain
- Athletic Recovery
- Metabolic Effects
- Mental Health: Depression, Anxiety, and Mood
- Sleep Quality
- Skin Conditions
- A Realistic Assessment of the Research
- Who Should Avoid Cryotherapy
- Setting Realistic Expectations
- Related Reading
- References
At a Glance
- Whole-body cryotherapy (WBC) exposes the body to extreme cold (-110°C to -140°C) for two to four minutes, triggering measurable anti-inflammatory, analgesic, and neuroendocrine responses [1].
- The strongest evidence supports WBC for inflammation reduction, pain management in inflammatory joint conditions, and short-term athletic recovery [2, 3].
- Promising but less definitive evidence exists for mental health benefits (depression, anxiety), metabolic activation, and sleep improvement [4, 5].
- People with uncontrolled hypertension, Raynaud’s disease, cold urticaria, untreated cardiovascular disease, or who are pregnant should not use whole-body cryotherapy.
- Most clinical benefits require repeated sessions (typically 10 to 20 over two to four weeks) rather than a single exposure.
How Cryotherapy Works: The Physiology of Extreme Cold
When skin temperature drops rapidly during a WBC session (surface temperature reaches roughly 0-5°C within 30 to 60 seconds), thermoreceptors send urgent signals to the hypothalamus, triggering several simultaneous responses [1, 6]:
- Peripheral vasoconstriction: Blood vessels in the skin and extremities constrict, shunting blood toward the core to protect vital organs. This redistribution concentrates blood flow through the body’s internal filtration systems.
- Norepinephrine surge: Plasma norepinephrine levels increase 200-300% during and immediately after a WBC session. Norepinephrine is both a neurotransmitter and a hormone involved in attention, focus, mood, and vasoconstriction [5].
- Anti-inflammatory signaling: Pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) decrease while anti-inflammatory cytokines (IL-10) increase. The NF-kB pathway, a master regulator of inflammatory gene expression, shows reduced activation after repeated cryotherapy sessions [2].
- Endorphin release: Beta-endorphin levels rise, contributing to pain relief and the sense of euphoria many users report after sessions.
- Post-session vasodilation: After leaving the chamber, blood vessels dilate as the body rewarms. This creates a “pumping” effect that enhances circulation and nutrient delivery to tissues.
The key insight: cryotherapy works through the body’s own adaptive responses to cold stress, not through direct tissue cooling. Two to four minutes is not long enough to significantly lower core temperature. It is a controlled stressor that activates beneficial physiological pathways.
Inflammation Reduction
This is where the evidence is strongest, and it is the mechanism underlying most of cryotherapy’s other benefits.
A 2014 systematic review published in Expert Review of Clinical Immunology examined the effects of WBC on inflammatory markers across multiple studies. The findings were consistent: repeated WBC sessions (typically 5 to 20 sessions over one to four weeks) produced significant reductions in pro-inflammatory cytokines IL-1beta, IL-6, and TNF-alpha, along with increases in anti-inflammatory IL-10 [2].
The NF-kB pathway deserves special attention. NF-kB is a transcription factor that controls inflammatory gene expression, turning on genes that produce inflammatory cytokines, adhesion molecules, and enzymes like COX-2. Chronic NF-kB overactivation is a hallmark of rheumatoid arthritis, inflammatory bowel disease, and metabolic syndrome [7]. A 2010 study by Lubkowska et al. demonstrated that 10 sessions of WBC over two weeks produced significant reductions in IL-6 and total oxidative stress markers in healthy subjects [8].
What this means practically: WBC is not just masking inflammation the way an NSAID does. It modulates the upstream signaling pathways that drive inflammatory cascades. That distinction matters for chronic conditions where long-term anti-inflammatory strategies are needed.
Pain Management
Cryotherapy’s pain-relieving effects operate through at least three distinct mechanisms: direct nerve conduction slowing, endorphin release, and downstream inflammation reduction.
Inflammatory Joint Conditions
The strongest pain-related evidence comes from studies on rheumatoid arthritis and ankylosing spondylitis. A systematic review by Guillot et al. (2014) evaluated WBC in inflammatory rheumatic diseases and found consistent evidence of pain reduction, improved joint function, and decreased disease activity scores when WBC was used alongside standard medical therapy [3].
In rheumatoid arthritis specifically, studies show that WBC reduces joint swelling, morning stiffness duration, and self-reported pain scores. Importantly, these improvements extended beyond the immediate analgesic effect of cold, suggesting that the anti-inflammatory mechanism produces lasting benefit [3].
Fibromyalgia
A 2016 randomized controlled trial studied WBC in fibromyalgia patients over three weeks (15 sessions). The WBC group showed significant improvements in pain scores, quality of life, and physical function compared to the control group. The effects persisted at the one-month follow-up assessment [9].
Post-Surgical Pain
Localized cryotherapy (rather than whole-body) has a longer evidence base for post-surgical pain management. However, WBC is increasingly used for post-surgical recovery in orthopedic and sports medicine settings, with clinicians reporting faster rehabilitation timelines and reduced analgesic medication use.
Athletic Recovery
This is the use case that brought cryotherapy into mainstream awareness. Professional sports teams and elite athletes have adopted WBC widely, but the scientific evidence is more nuanced than the marketing suggests.
A 2017 review by Rose et al. in the International Journal of Sports Medicine analyzed the available evidence on WBC for exercise recovery. The findings were mixed but generally favorable for subjective recovery measures (muscle soreness, perceived fatigue) and less consistent for objective markers (blood markers, muscle function) [10].
What the evidence supports:
- Reduced delayed-onset muscle soreness (DOMS): Multiple studies show that WBC after intense exercise reduces subjective muscle soreness over the following 24 to 72 hours compared to passive recovery [10, 11].
- Faster perceived recovery: Athletes consistently report feeling recovered more quickly after WBC, which has practical value for multi-day competitions or heavy training blocks.
- Reduced muscle damage markers: Some studies show decreased creatine kinase (CK) levels after WBC, though results are inconsistent across the literature [11].
What the evidence does not clearly support:
- Enhanced muscle adaptation: A 2015 study by Roberts et al. found that cold water immersion after resistance training attenuated long-term muscle mass and strength gains [12]. Whether WBC has the same effect is not definitively established, but athletes focused on hypertrophy should consider timing.
- Superior performance in subsequent training: While athletes feel better, objective performance measures (power output, sprint times) in subsequent training sessions are not consistently improved by WBC.
The practical takeaway for athletes: WBC appears most useful during competition periods, tournament weekends, or training blocks where rapid recovery between sessions is the priority. During dedicated strength-building phases, timing cold exposure away from resistance training (at least four to six hours) may be the better approach.
Metabolic Effects
The claim that cryotherapy “burns calories” and “boosts metabolism” is one of the more overstated marketing angles, but there is a kernel of real physiology underneath it.
Extreme cold exposure activates brown adipose tissue (BAT), a metabolically active form of fat that generates heat through non-shivering thermogenesis. BAT activation increases energy expenditure and glucose uptake. A single WBC session has been estimated to increase metabolic rate by 200 to 350 calories over several hours, though individual variation is large and depends on BAT volume and activity [13].
More relevant than acute calorie burn is the potential for repeated cold exposure to increase BAT recruitment over time. Studies on regular cold exposure show increases in BAT volume and activity after several weeks of consistent practice [13]. No study has demonstrated clinically significant weight loss from WBC alone, so think of it as one input in a broader metabolic health strategy rather than a standalone weight loss tool.
Mental Health: Depression, Anxiety, and Mood
This is an area of growing research interest, and the early findings are genuinely compelling.
The primary mechanism is the dramatic norepinephrine increase produced by cold exposure. Norepinephrine is not just a “stress hormone.” It is a key neurotransmitter in the brain’s arousal and mood regulation circuits. Low norepinephrine activity is associated with depression, attention deficits, and low energy. The 200-300% increase in norepinephrine from a single WBC session rivals the effect of some antidepressant medications [5].
A 2008 study by Rymaszewska et al. examined WBC as an adjunct treatment for depressive and anxiety disorders. Patients who received 15 WBC sessions over three weeks, alongside their standard psychiatric care, showed significantly greater improvements in depression and anxiety scores compared to patients receiving standard care alone [4].
Beta-endorphin release during WBC sessions also contributes to the mood-elevating effect. Many regular cryotherapy users describe a post-session “high” characterized by improved mood, heightened alertness, and a sense of calm. This subjective experience aligns with the norepinephrine and endorphin data. While more large-scale clinical trials are needed, the existing evidence suggests that WBC may be a valuable non-pharmacological tool for mood disorders, particularly as an adjunct to conventional treatment.
Sleep Quality
Improved sleep is one of the most commonly reported benefits among regular cryotherapy users, and there is physiological reasoning behind it.
Sleep onset requires a drop in core body temperature. WBC produces peripheral vasoconstriction followed by post-session vasodilation, which facilitates heat dissipation and may support the natural temperature decline needed for sleep. The Rymaszewska studies noted significant improvements in sleep quality among psychiatric patients receiving WBC [4, 14]. Dedicated sleep-focused trials are limited, but the consistent subjective reports and supporting physiological mechanisms make this a plausible benefit.
Skin Conditions
WBC has been studied in several dermatological conditions, particularly atopic dermatitis (eczema) and psoriasis. The anti-inflammatory mechanism is the primary driver: both conditions involve overactive inflammatory pathways in the skin [2].
Studies report reduced itching, improved skin barrier function, and decreased disease severity scores after repeated WBC sessions. A small study on atopic dermatitis patients found that 30 WBC sessions over six weeks reduced disease severity and improved quality of life measures [15]. The evidence base is limited to small studies, but the results are encouraging enough to warrant further investigation.
A Realistic Assessment of the Research
Transparency about research quality matters. Here is where things stand:
- Strong evidence: Anti-inflammatory cytokine changes, pain reduction in inflammatory joint conditions, reduced muscle soreness after exercise.
- Moderate evidence: Mood improvement, anxiety reduction, norepinephrine-mediated physiological effects.
- Preliminary evidence: Metabolic activation, sleep quality, skin condition improvement, immune modulation.
- Limited evidence: Long-term weight management, anti-aging effects, cognitive performance enhancement.
Many WBC studies are limited by small sample sizes, lack of proper blinding (it is difficult to create a convincing placebo for stepping into a -130°C chamber), and short follow-up periods. The 2015 Cochrane review on WBC for exercise recovery concluded that the evidence was insufficient to determine whether WBC was superior to passive rest, though they acknowledged significant methodological limitations in the available studies [11].
None of this means WBC does not work. It means the research is still catching up with clinical practice and patient experience. The biological mechanisms are well characterized, the safety profile is established, and the consistency of positive reports across different populations is noteworthy.
Who Should Avoid Cryotherapy
WBC is not appropriate for everyone. Established contraindications include:
- Uncontrolled hypertension: The vasoconstriction response can raise blood pressure acutely
- Raynaud’s disease: Extreme cold can trigger severe vasospastic episodes
- Cold urticaria: An allergic reaction to cold that can cause hives, swelling, and in severe cases, anaphylaxis
- Untreated cardiovascular disease: The acute sympathetic activation and blood pressure changes pose risks
- Pregnancy: Insufficient safety data
- Cryoglobulinemia: Cold exposure can trigger precipitation of abnormal proteins
- Active cancer: Some practitioners consider this a contraindication, though this remains debated
- Children under 14: Most facilities restrict access based on age
Any reputable cryotherapy facility will conduct a health screening before your first session. If they do not ask about these conditions, find a different provider.
Setting Realistic Expectations
Cryotherapy is a tool, not a cure. Here is a grounded framework for thinking about what it can and cannot do:
- Best for: Reducing systemic inflammation, managing pain in inflammatory conditions, accelerating recovery between athletic events, supporting mood and energy as part of a comprehensive wellness plan.
- Requires consistency: Most studied protocols involve 10 to 20 sessions over two to four weeks. A single session may provide temporary symptom relief, but lasting changes in inflammatory markers and clinical outcomes require repeated exposure.
- Works best as part of a broader strategy: Cryotherapy alone is unlikely to resolve a complex health condition. It is most effective when combined with appropriate medical treatment, nutrition, exercise, sleep optimization, and stress management.
- Not a replacement for medical care: WBC is a complementary therapy. If you have an inflammatory condition, work with a qualified healthcare provider to develop a comprehensive treatment plan.
Related Reading
- Cryotherapy Near Me: How to Find a Safe, Effective Provider
- Chronic Pain Management Without Opioids: Evidence-Based Alternatives
- Chronic Fatigue Treatment: Evidence-Based Options
- IV Therapy Benefits and Risks: What the Evidence Says
- Psoriasis Treatment Options: A Complete Guide
References
- Bleakley CM, Bieuzen F, Davison GW, Costello JT. “Whole-body cryotherapy: empirical evidence and theoretical perspectives.” Open Access J Sports Med. 2014;5:25-36. doi:10.2147/OAJSM.S41655
- Guillot X, Tordi N, Mourot L, et al. “Cryotherapy in inflammatory rheumatic diseases: a systematic review.” Expert Rev Clin Immunol. 2014;10(2):281-294. doi:10.1586/1744666X.2014.870036
- Stanek A, Cholewka A, Gadula J, et al. “Can whole-body cryotherapy with subsequent kinesiotherapy procedures in closed type cryogenic chamber improve BASDAI, ## BASFI, and some spine mobility parameters and decrease pain intensity in patients with ankylosing spondylitis?” Biomed Res Int. 2015;2015:404259. doi:10.1155/2015/404259
- Rymaszewska J, Ramsey D, Chładzińska-Kiejna S. “Whole-body cryotherapy as adjunct treatment of depressive and anxiety disorders.” Arch Immunol Ther Exp. 2008;56(1):63-68. doi:10.1007/s00005-008-0006-5
- Leppäluoto J, Westerlund T, Huttunen P, et al. “Effects of long-term whole-body cold exposures on plasma concentrations of ACTH, beta-endorphin, cortisol, catecholamines and cytokines in healthy females.” Scand J Clin Lab Invest. 2008;68(2):145-153. doi:10.1080/00365510701516350
- Westerlund T, Oksa J, Smolander J, Mikkelsson M. “Thermal responses during and after whole-body cryotherapy (-110°C).” J Therm Biol. 2003;28(8):601-608. doi:10.1016/j.jtherbio.2003.08.006
- Lawrence T. “The nuclear factor NF-kappaB pathway in inflammation.” Cold Spring Harb Perspect Biol. 2009;1(6):a001651. doi:10.1101/cshperspect.a001651
- Lubkowska A, Szygula Z, Klimek AJ, Torii M. “Do sessions of cryostimulation have influence on white blood cell count, level of IL6 and total oxidative and antioxidative status in healthy men?” Eur J Appl Physiol. 2010;109(1):67-72. doi:10.1007/s00421-009-1207-2
- Rivera J, Tercero MJ, Salas JS, et al. “The effect of cryotherapy on fibromyalgia: a randomised clinical trial carried out in a cryosauna cabin.” Rheumatol Int. 2018;38(12):2243-2250. doi:10.1007/s00296-018-4176-0
- Rose C, Edwards KM, Siegler J, et al. “Whole-body cryotherapy as a recovery technique after exercise: a review of the literature.” Int J Sports Med. 2017;38(14):1049-1060. doi:10.1055/s-0043-114861
- Costello JT, Baker PR, Minett GM, et al. “Whole-body cryotherapy (extreme cold air exposure) for preventing and treating muscle soreness after exercise in adults.” Cochrane Database Syst Rev. 2015;(9):CD010789. doi:10.1002/14651858.CD010789.pub2
- Roberts LA, Raastad T, Markworth JF, et al. “Post-exercise cold water immersion attenuates acute anabolic signalling and long-term adaptations in muscle to strength training.” J Physiol. 2015;593(18):4285-4301. doi:10.1113/JP270570
- van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. “Cold-activated brown adipose tissue in healthy men.” N Engl J Med. 2009;360(15):1500-1508. doi:10.1056/NEJMoa0808718
- Okamoto-Mizuno K, Mizuno K. “Effects of thermal environment on sleep and circadian rhythm.” J Physiol Anthropol. 2012;31(1):14. doi:10.1186/1880-6805-31-14
- Klimenko T, Ahvenainen S, Karvonen SL. “Whole-body cryotherapy in atopic dermatitis.” Arch Dermatol. 2008;144(6):806-808. doi:10.1001/archderm.144.6.806



